Page 11234..10..»


Category Archives: Hypogonadism

Clarus Therapeutics Lauches JATENZO – Oral Testosterone Replacement Therapy – MedicalResearch.com


Posted: February 24, 2020 at 3:55 am

MedicalResearch.com Interview with: Robert E. Dudley, Ph.D.Chairman, Chief Executive Officer and PresidentClarus Therapeutics Dr. Dudley discusses the recent announcement that Clarus Therapeutics, Inc Continue reading

Posted in Hypogonadism | Comments Off on Clarus Therapeutics Lauches JATENZO – Oral Testosterone Replacement Therapy – MedicalResearch.com

Jatenzo, an Oral Testosterone Replacement Therapy, Now Available – Renal and Urology News


Posted: February 24, 2020 at 3:55 am

Jatenzo (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism. Specifically, Jatenzo is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Jatenzo is not intended for use in males with age-related hypogonadism and its safety and efficacy have not been established in males Continue reading

Posted in Hypogonadism | Comments Off on Jatenzo, an Oral Testosterone Replacement Therapy, Now Available – Renal and Urology News

6 Serious Health Conditions Linked To Erectile Dysfunction – The African Exponent


Posted: February 19, 2020 at 8:50 am

6 Serious Health Conditions Linked To Erectile Dysfunction There is a connection between ED and dementia, heart disease, and other diseases. We frequently think of erectile dysfunction as a minor consequence or side effect of getting older, and that makes sense. After all, some data show that more than half of all men ages 40 to 70 have some form of erectile dysfunction. Continue reading

Posted in Hypogonadism | Comments Off on 6 Serious Health Conditions Linked To Erectile Dysfunction – The African Exponent

Jatenzo, an Oral Testosterone Replacement Therapy, Now Available – Monthly Prescribing Reference


Posted: February 12, 2020 at 7:49 pm

Jatenzo (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism. Specifically, Jatenzo is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Jatenzo is not intended for use in males with age-related hypogonadism and its safety and efficacy have not been established in males Continue reading

Posted in Hypogonadism | Comments Off on Jatenzo, an Oral Testosterone Replacement Therapy, Now Available – Monthly Prescribing Reference

Male Hypogonadism to Witness Growth Acceleration During 2018 2028 – Redhill Local Councillors


Posted: February 12, 2020 at 7:49 pm

The study on the Male Hypogonadism Market Research delivers a profound comprehension of the market dynamics like drivers, the challenges, trends, and opportunities. The analysis further elaborates on the micro and macro-economic facets which can be predicted to shape the increase of the Male Hypogonadism Market through the forecast period (2019-2029). The study elucidates the crucial indexes of Male Hypogonadism Market expansion which contains a comprehensive analysis of CAGR development this value series, and Porters Five Forces Analysis. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism to Witness Growth Acceleration During 2018 2028 – Redhill Local Councillors

Male Hypogonadism Therapy Market Size Current and Future Industry Trends, 2020- – News by aeresearch


Posted: February 12, 2020 at 7:49 pm

Latest Research Report on Male Hypogonadism Therapy Market size | Industry Segment by Applications (Hospitals, Drugstores and Others), by Type (Parenteral, Transdermal, Oral and Others), Regional Outlook, Market Demand, Latest Trends, Male Hypogonadism Therapy Industry Growth, Share & Revenue by Manufacturers, Company Profiles, Forecasts 2025.Analyzes current market size and upcoming 5 years growth of this industry. Continue reading

Posted in Hypogonadism | Comments Off on Male Hypogonadism Therapy Market Size Current and Future Industry Trends, 2020- – News by aeresearch

Global Male Hypogonadism Market 2019 Comprehensive Study with On-Going Trends, Majors Players and Forecast 2025 – Global Newspaper


Posted: February 5, 2020 at 8:45 am

A leading research firm, Zion Market Research added a latest industry report on "Global Male Hypogonadism Market" consisting of 110+ pages during the forecast period and Male Hypogonadism Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Male Hypogonadism Market. Continue reading

Posted in Hypogonadism | Comments Off on Global Male Hypogonadism Market 2019 Comprehensive Study with On-Going Trends, Majors Players and Forecast 2025 – Global Newspaper

Mineral and Hormonal Dysfunction Associated With Lower BMD in Thalassemia Major – Endocrinology Advisor


Posted: February 3, 2020 at 7:43 pm

Hypothyroidism, hyperglycemia, and low adrenocorticotrophic hormone (ACTH) levels are associated with lower bone mass in patients with thalassemia major, according to study results published in The Journal of Clinical Endocrinology & Metabolism. The major mechanisms of endocrine dysfunction that lead to decreased bone mineral density (BMD) and increased risk for fracture in patients with thalassemia major remain poorly understood Continue reading

Posted in Hypogonadism | Comments Off on Mineral and Hormonal Dysfunction Associated With Lower BMD in Thalassemia Major – Endocrinology Advisor

The Rape Case Against Nithyananda Should Be Dropped If They Had Sex, She Obviously Wanted It! – Frank Report


Posted: February 3, 2020 at 7:43 pm

By Marie White Nithyananda Swami is accused of raping a woman named Aarthi Rao some 40 times over a period of five years. There are three arguments that suggest the criminal accusation is false. Aarthi Rao, alleged victim of rape. Continue reading

Posted in Hypogonadism | Comments Off on The Rape Case Against Nithyananda Should Be Dropped If They Had Sex, She Obviously Wanted It! – Frank Report

Mineral, Hormonal Dysfunction Associated With Lower BMD in Thalassemia Major – Rheumatology Advisor


Posted: January 31, 2020 at 1:41 pm

Hypothyroidism, hyperglycemia, and low adrenocorticotrophic hormone (ACTH) levels are associated with lower bone mass in patients with thalassemia major, according to study results published in The Journal of Clinical Endocrinology & Metabolism. The major mechanisms of endocrine dysfunction that lead to decreased bone mineral density (BMD) and increased risk for fracture in patients with thalassemia major remain poorly understood. Continue reading

Posted in Hypogonadism | Comments Off on Mineral, Hormonal Dysfunction Associated With Lower BMD in Thalassemia Major – Rheumatology Advisor

Page 11234..10..»